Research areas: Depression
Major Depression is a serious psychiatric disease that, in our country, affects some 6 million individuals. Its lifetime prevalence is 8.9% for men and 16.5% for women, and its incidence has been increasing in recent decades.
Depression is characterised by mood, behavioural, and physical changes; it is often recurrent, becoming chronic in 25% of cases, and may occur at any age, causing great disability in the patients who experience it. In fact, according to a study published by the World Health Organisation, Major Depression (MD) will be the second leading cause of disability in the year 2020. It is a far-reaching public health problem with a high economic, societal, and personal cost, since, for example, MD is present in 70% of completed suicides.
It is estimated that only half of patients with Major Depression are detected and correctly diagnosed and, of those, not all receive appropriate treatment.
CIBERSAM Research Objectives in Depressive Disorder
The CIBERSAM’s general objective is to promote co-operative and translational research to decrease the public health, societal, and personal costs associated with depressive disease, through quality research in the areas of epidemiology, etiopathogenesis, physiopathology, prevention, and therapeutics, in addition to facilitating the dissemination of that information to the National Health System.
Co-ordination and Member Groups
- Co-ordinator: Victor Pérez Sola
-
Member Groups:
- Hospital Sant Creu i Sant Pau, Barcelona (Victor Pérez Sola)
- Universidad de Cantabria, Santander (Ángel Pazos Carro)
- Universidad de País Vasco, Leioa-Bizkaia (Javier Meana Martínez)
- Universidad de Barcelona, Barcelona (Lourdes Fañanas Saura)
- Universidad de Granada, Granada (Jorge Cervilla Ballesteros)
- Instituto de Investigaciones Biomédicas de Barcelona, Barcelona (Francesc Artigas Pérez)
- Instituto Cajal - CSIC, Madrid (Javier Garzón Niño)
